Life sciences is heading toward a platform approach. According to Gartner, digital life science platforms are on track to be mainstream within five to 10 years.
For emerging pharmaceutical companies, platforms offer a distinct opportunity to reach customers without spending years building digital capabilities. Instead, prebuilt, out-of-the-box industry tools can jump-start the ability to deliver customers the experiences they expect.
Watch this webinar if you are a leader building commercial or analytics capabilities in the areas of biotech, oncology or cell and gene therapy.
- Hear why you have a distinct opportunity to leverage platforms to compete in today’s dynamic healthcare ecosystem.
- Understand what platforms do to help strengthen or build analytics and commercial operations.
- Learn how our platform, ZAIDYN™, brings together customer engagement, field performance and business analytics to help companies at all stages of maturity.